Dogwood Therapeutics, Inc. (DWTX)
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 20262 patents granted to the 3 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Dogwood Therapeutics, Inc.’s names, not what it holds today.
5 published
0 published
1 published
Names not counted (2)
| Granted | Patent | Title | Field | Owner as printed |
|---|---|---|---|---|
| Aug 24, 2021 | 11,096,912 | Valaciclovir and celecoxib combination for functional somatic syndromes | Pharmaceuticals | VIRIOS THERAPEUTICS, INC. |
| Dec 11, 2018 | 10,149,852 | Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy | Pharmaceuticals | Wex Pharmaceuticals Inc. |
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| Dec 25, 2025 | 2025/0388596 | PROCESS FOR THE EXTRACTION AND PURIFICATION OF TETRODOTOXIN | Organic fine chemistry | Wex Pharmaceuticals Inc. |
| Jul 11, 2024 | 2024/0226105 | TETRODOTOXIN LIQUID FORMULATIONS | Pharmaceuticals | Wex Pharmaceuticals Inc. |
| Aug 26, 2010 | 2010/0215771 | USE OF SODIUM CHANNEL BLOCKERS FOR THE TREATMENT OF NEUROPATHIC PAIN DEVELOPING AS A CONSEQUENCE OF CHEMOTHERAPY | Pharmaceuticals | Wex Pharmaceuticals Inc. · patent 9,018,222 granted from it |
| Jun 10, 2010 | 2010/0144767 | Use of sodium channel blockers for the treatment of visceral pain or pain caused by cancer treatment | Pharmaceuticals | Wex Pharmaceuticals Inc. |
| Feb 25, 2010 | 2010/0048592 | Use of sodium channel blockers for the management of musculoskeletal pain | Pharmaceuticals | Wex Pharmaceuticals Inc. |
| Jun 4, 2009 | 2009/0143415 | Tetrodotoxin And Its Derivatives For The Treatment Of Central-Nervously Derived Neuropathic Pain | Pharmaceuticals | Wex Pharmaceuticals Inc. |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.